Zacks

Zacks Small Cap Research – HIT: Newly Formed Advisory Board and Advisor With Extensive Public Affairs Experience Appear Timely – Go Health Pro

by

By M. Marin NASDAQ:HIT READ THE FULL HIT RESEARCH REPORT New Board member: extensive experience in public affairs & policy… Health in Tech (NASDAQ:HIT) is an insurtech operating an AI-powered online marketplace platform to facilitate and improve employers’ ability to obtain health insurance. The company, which provides enterprise SaaS (Software-as-a-Service) solutions for online processing and … Read more

Zacks Small Cap Research – GMGI: Balance Sheet Strengthened, Financial Flexibility Enhanced, With Debt Reduction – Go Health Pro

by
Zacks Small Cap Research – GMGI: Balance Sheet Strengthened, Financial Flexibility Enhanced, With Debt Reduction – Go Health Pro

By M. Marin NASDAQ:GMGI READ THE FULL GMGI RESEARCH REPORT Balance sheet strengthened with debt reduction Golden Matrix Group (NASDAQ:GMGI), an iGaming group providing a broad array of gaming products and software solutions on a B2B and B2C basis, strengthened its balance sheet by paying down debt. The company had issued Lind Global Asset Management … Read more

Zacks Small Cap Research – EVAX Provided Great Cancer Vaccine Update – Go Health Pro

by

By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it can identify, through the company’s AI models, novel targets within … Read more

Zacks Small Cap Research – LEXX: Second Quarter Results – Go Health Pro

by
Zacks Small Cap Research – LEXX: Second Quarter Results – Go Health Pro

By John Vandermosten, CFA NASDAQ:LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal second quarter 2025 results through the filing of its Form 10-Q. Since our previous update, the company has made progress with its multiple GLP-1 trials, received patent awards in epilepsy and shared its strategy for advancing its development … Read more

Zacks Small Cap Research – Fireside Chat with Christopher Schaber, Chief Executive Officer of Soligenix, Inc. – Go Health Pro

by

NASDAQ:SNGX David Bautz: Hi, everyone, and welcome to the next episode of our CEO Fireside Chats. My name is David Bautz and I’m a senior biotechnology analyst here at Zacks Small Cap Research. Joining me today is Chris Schaber. He is the Chief Executive Officer of Soligenix, Inc. They are a late-stage biopharmaceutical company focused … Read more